To determine whether p53 plays a role in the inhibitory action of X15695 in the prostate cancer cells, an attenuation of the X15695-mediated decrease in viability of the three prostate cancer cells was determined after p53 knockdown by siRNA transfection (Fig. 7H). This evidence concerns the gene TP53 and prostate carcinoma.